Search Results - "YALCIN, Suayib"

Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience by Simsek, Cem, Yalcin, Suayib, Esin, Ece

“…Metronomic chemotherapy, continuous and dose-dense administration of chemotherapeutic drugs with lowered doses, is being evaluated for substituting,…”
Get full text

The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis by Guven, Deniz Can, Sahin, Taha Koray, Erul, Enes, Rizzo, Alessandro, Ricci, Angela Dalia, Aksoy, Sercan, Yalcin, Suayib

“…The albumin levels may potentially be used as a prognostic biomarker in patients with cancertreated with immune checkpoint inhibitors (ICIs) due to its close…”
Get full text

The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer by Lacin, Sahin, Yalcin, Suayib

“…Background: Neovascularization plays a crucial pathogenic role in tumor development and vascular endothelial growth factor (VEGF-A) is a key signaling element…”
Get full text

Examining guidelines and new evidence in oncology nutrition: a position paper on gaps and opportunities in multimodal approaches to improve patient care by Prado, Carla M., Laviano, Alessandro, Gillis, Chelsia, Sung, Anthony D., Gardner, Maureen, Yalcin, Suayib, Dixon, Suzanne, Newman, Shila M., Bastasch, Michael D., Sauer, Abby C., Hegazi, Refaat, Chasen, Martin R.

“…Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognized…”
Get full text

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations by Tsaousis, Georgios N, Papadopoulou, Eirini, Apessos, Angela, Agiannitopoulos, Konstantinos, Pepe, Georgia, Kampouri, Stavroula, Diamantopoulos, Nikolaos, Floros, Theofanis, Iosifidou, Rodoniki, Katopodi, Ourania, Koumarianou, Anna, Markopoulos, Christos, Papazisis, Konstantinos, Venizelos, Vasileios, Xanthakis, Ioannis, Xepapadakis, Grigorios, Banu, Eugeniu, Eniu, Dan Tudor, Negru, Serban, Stanculeanu, Dana Lucia, Ungureanu, Andrei, Ozmen, Vahit, Tansan, Sualp, Tekinel, Mehmet, Yalcin, Suayib, Nasioulas, George

“…Hereditary cancer predisposition syndromes are responsible for approximately 5-10% of all diagnosed cancer cases. In the past, single-gene analysis of specific…”
Get full text

Concomitant RAS and BRAF mutation in colorectal cancer - A report of 7 cases by Ates, Ozturk, Yalcin, Suayib

“…Rat sarcoma viral oncogene homolog (RAS) and B-Raf murine sarcoma viral oncogene homolog B1 (BRAF) are members of the same signaling pathway…”
Get full text

Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy by Guven, Deniz Can, Aksun, Melek Seren, Sahin, Taha Koray, Aktepe, Oktay Halit, Yildirim, Hasan Cagri, Taban, Hakan, Ceylan, Furkan, Kertmen, Neyran, Arik, Zafer, Dizdar, Omer, Kilickap, Saadettin, Aksoy, Sercan, Yalcin, Suayib, Erman, Mustafa

“…Purpose Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in cancer patients. However, the association of VTE with immunotherapy…”
Get full text

Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: PRECONNECT Turkey by Özet, Ahmet, Dane, Faysal, Aykan, Nuri Faruk, Yalçın, Şuayib, Evrensel, Türkkan, Özkan, Metin, Karabulut, Bülent, Ormeci, Merve Nur, Atasev, Ozan, Vidot, Loïck, Çiçin, İrfan

“…The efficacy and safety of trifluridine/tipiracil (FTD/TPI) for third-line treatment of metastatic colorectal cancer have been demonstrated. The authors…”
Get full text

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine by Carloni, Riccardo, Rizzo, Alessandro, Ricci, Angela Dalia, Federico, Alessandro Di, De Luca, Raffaele, Guven, Deniz Can, Yalcin, Suayib, Brandi, Giovanni

“…•CCA has a dismal prognosis, and it is usually diagnosed in advanced stage for which available treatments have limited efficacy.•CCA TME presents an abundant…”
Get full text

Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group by Ünal, Çağlar, Azizy, Abdulmunir, Karabulut, Senem, Taştekin, Didem, Akyıldız, Arif, Yaşar, Serkan, Yalçın, Şuayib, Çoban, Eyüp, Evrensel, Türkkan, Kalkan, Ziya, Oruç, Zeynep, Derin, Sümeyra, Turna, Zeynep Hande, Bayram, Doğan, Köş, Fahriye Tuğba, Şendur, Mehmet Ali Nihat, Sever, Nadiye, Ercelep, Özlem, Seyyar, Mustafa, Kefeli, Umut, Uygun, Kazım, Özçelik, Melike, Ön, Sercan, Şanlı, Ulus Ali, Canaslan, Kübra, Ünek, İlkay Tuba, Yücel, Kadriye Bir, Özdemir, Nuriye, Yazıcı, Ozan, Güzel, Halil Göksel, Salim, Derya Kıvrak, Göksu, Sema Sezgin, Tatlı, Ali Murat, Ordu, Çetin, Selvi, Oğuzhan, Sakin, Abdullah, Büyükbayram, Mehmet Emin, Dursun, Bengü, Ürün, Yüksel, Arak, Hacı, Ağdaş, Gözde, Uğraklı, Muzaffer, Hendem, Engin, Eryılmaz, Melek Karakurt, Bilgin, Burak, Topçu, Atakan, Şimşek, Melih, Büyükşimşek, Mahmut, Akay, Büşra, Erdal, Gülçin Şahingöz, Karataş, Fatih, Alan, Özkan, Çağlayan, Melek, Kahvecioğlu, Fatma Akdağ, Demirci, Ayşe, Paksoy, Nail, Çetin, Bülent, Gümüş, Mahmut, Ak, Naziye, Aydınalp, Yasemin, Paydaş, Semra, Güven, Deniz Can, Kılıçkap, Saadettin, Sağlam, Sezer

“…Abstract Introduction This study aims to report the efficacy and safety of capecitabine plus temozolomide (CAPTEM) across different lines of treatment in…”
Get full text

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment by Gürler, Fatih, İlhan, Ayşegül, Güven, Deniz Can, Turhan, Okan, Kurt İnci, Bediz, Sütçüoğlu, Osman, Yildiz, Fatih, Arik, Zafer, Öksüzoğlu, Berna, Yalçin, Şuayib, Özdemir, Nuriye, Yazici, Ozan, Özet, Ahmet

“…We aimed to compare the efficacy and the safety of the FOLFOX and the FLOT regimens in metastatic gastric cancer (mGC) as first-line treatment. It was a…”
Get full text

The Use of Herbal Medicine and Dietary Supplements in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Cross-Sectional Study by Kus, Fatih, Can Guven, Deniz, Yildirim, Hasan Cagri, Akagunduz, Baran, Karakaya, Serdar, Sutcuoglu, Osman, Chalabiyev, Elvin, Akyildiz, Arif, Koksal, Baris, Sahin, Yigit Berk, Karaca, Ece, Kavruk, Oguz Alp, Zor, Nefise Tugce, Sirvan, Firat, Yazici, Ozan, Yalcin, Suayib

“…This study aimed to assess the habits and knowledge of cancer patients regarding the use of herbal medicines and dietary supplements in cancer patients…”
Get full text

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study by Yalcin, Suayib, Dane, Faysal, Oksuzoglu, Berna, Ozdemir, Nuriye Yildirim, Isikdogan, Abdurrahman, Ozkan, Metin, Demirag, Guzin Gonullu, Coskun, Hasan Senol, Karabulut, Bulent, Evrensel, Turkkan, Ustaoglu, Mehmet Ali, Ozdemir, Feyyaz, Turna, Hande, Yavuzsen, Tugba, Aykan, Faruk, Sevinc, Alper, Akbulut, Hakan, Yuce, Deniz, Hayran, Mutlu, Kilickap, Saadettin

“…Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL)…”
Get full text

The platelet to lymphocyte ratio predicts overall survival better than the neutrophil to lymphocyte ratio in metastatic renal cell carcinoma by Aktepe, Oktay Halit, Güner, Gürkan, Güven, Deniz Can, Şahin, Taha Koray, Ardıç, Fadime Sinem, Yüce, Deniz, Yalçın, Şuayib, Erman, Mustafa

“…The prognostic values of systemic inflammatory markers, neutrophil to lymphocyte ratio (NLR), and platelet to lymphocyte ratio (PLR) on overall survival (OS)…”
Get full text

The burden of polypharmacy and drug–drug interactions in older cancer patients treated with immunotherapy by Guven, Deniz C, Kavgaci, Gozde, Aktepe, Oktay H, Yildirim, Hasan C, Sahin, Taha K, Aksoy, Sercan, Erman, Mustafa, Kilickap, Saadettin, Yalcin, Suayib

“…Introduction Polypharmacy is a common problem in older cancer patients, although the data about polypharmacy and potentially inappropriate prescription…”
Get full text

Real world survival data of a rare malignancy: Anal cancer results in HIV negative patients from Turkey by Esin, Ece, Yildiz, Ferah, Lacin, Sahin, Karakas, Yusuf, Gultekin, Melis, Dizdar, Omer, Yalcin, Suayib

“…Background/Aims: An organ preservation approach using chemoradiotherapy has been established for anal cancer. This retrospective cohort study aimed to define…”
Get full text

Retrospective comparison of flot and modified dcf as first-line chemotherapy in metastatic gastric adenocarcinoma by Gürler, Fatih, Güven, Deniz Can, Aydemir, Ergin, Sütçüoğlu, Osman, İnci, Bediz Kurt, Arık, Zafer, Yalçın, Şuayib, Özdemir, Nuriye, Özet, Ahmet, Yazıcı, Ozan

“…The aim of our study was to compare the efficacy and the safety of the FLOT and the modified DCF (mDCF) regimens in patients with metastatic gastric (GC) and…”
Get full text

Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival by Turkoz, Fatma Paksoy, Solak, Mustafa, Kilickap, Saadettin, Ulas, Arife, Esbah, Onur, Oksuzoglu, Berna, Yalcin, Suayib

“…To evaluate the incidence, clinicopathological characteristics, treatment outcomes, prognostic factors, and survival of gastric cancer patients with bone…”
Get full text

Survival of Patients With Metastatic Rectum Cancer Who Underwent Metastasectomy Following Conversion Chemotherapy Sans Pelvic Radiotherapy: A Turkish Oncology Group Study by Almuradova, Elvina, Yalcin, Suayib, Arıkan, Rukiye, Ayhan, Murat, Demir, Hacer, Cevik, Gokcen Tugba, Karaca, Mustafa, Petekkaya, Ibrahim, Karabulut, Bulent

“…The management of early rectal cancer is different from that of colon cancer in terms of radiotherapy (RT) requirements or neoadjuvant treatment. It is not…”
Get full text

Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience by Karakas, Yusuf, Lacin, Sahin, Kurtulan, Olcay, Esin, Ece, Sunar, Veli, Sokmensuer, Cenk, Kilickap, Saadettin, Yalcin, Suayib

“…Background/Aims: Gastric neuroendocrine tumors (G-NETs) are rare tumors, but their incidence is gradually increasing. Despite the existence of many…”
Get full text